New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
DexCom, Inc.
DXCM
Shape
US Flag

NASDAQ

28B

Medical - Devices

71.91USD
Shape-0.20 ( -0.27%)
Market Open
favorite-chart

Relative Strenght

73
favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

49%

Quote Panel

Shape
Updated October 29, 2024
1W -0.75 % 1M 7.31 % 3M 3.21 % 1Y -15.27 %

Key Metrics

Shape
  • Market Cap

    28.09B


  • Shares Outstanding

    390.60M


  • Share in Float

    385.36M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    71.905


  • Average Volume

    5.10M


  • Beta

    1.18


  • Range

    62.34-142.0


  • Industry

    Medical - Devices


  • Website

    https://www.dexcom.com


  • Sector

    Healthcare


Fundamentals

Shape

42.32x

P/E Ratio

7.07x

P/S Ratio

14.25x

P/B Ratio

1.3

Debt/Equity

17.2%

Net Margin

$1.6

EPS

How DXCM compares to sector?

P/E Ratio

Relative Strength

Shape

DXCM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape366%

2025-Revenue

$1.99

Shape486%

2025-EPS

$759M

Shape399%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

RBC Capital

initialise

Previous: Not converted

2024-03-12

Now: Outperform

Raymond James

upgrade

Previous: Outperform

2023-04-17

Now: Strong Buy

Bernstein

initialise

Previous: Not converted

2022-07-15

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+100%

0.34
vs 0.17

Q1.23

arrow
arrow

+113%

0.17
vs 0.08

Q2.23

arrow
arrow

+100%

0.34
vs 0.17

Q3.23

arrow
arrow

+79%

0.5
vs 0.28

Q4.23

arrow
arrow

+47%

0.5
vs 0.34

Q1.24

arrow
arrow

+88%

0.32
vs 0.17

Q2.24

arrow
arrow

+26%

0.43
vs 0.34

Q3.24

arrow
arrow

-10%

0.45
vs 0.5

Q4.24

arrow
arrow

+3%

0.51
vs 0.5

Q1.25

arrow
arrow

+22%

0.39
vs 0.32

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+17%

815.2M  vs 698.2M

Q1.23

arrow
arrow

+18%

741.5M  vs 628.8M

Q2.23

arrow
arrow

+25%

871.3M  vs 696.2M

Q3.23

arrow
arrow

+27%

975M  vs 769.6M

Q4.23

arrow
arrow

+27%

1B  vs 815.2M

Q1.24

arrow
arrow

+24%

921M  vs 741.5M

Q2.24

arrow
arrow

+15%

1B  vs 871.3M

Q3.24

arrow
arrow

+2%

994.2M  vs 975M

Q4.24

arrow
arrow

+6%

1.1B  vs 1B

Q1.25

arrow
arrow

+13%

1B  vs 921M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+4%

0.04
vs 0.06

Q1.23

arrow
arrow

+2%

0.02
vs 0.04

Q2.23

arrow
arrow

+6%

0.06
vs 0.02

Q3.23

arrow
arrow

+5%

0.05
vs 0.06

Q4.23

arrow
arrow

+12%

0.12
vs 0.05

Q1.24

arrow
arrow

+7%

0.07
vs 0.12

Q2.24

arrow
arrow

+6%

0.06
vs 0.07

Q3.24

arrow
arrow

+7%

0.07
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

833

833
vs 838

-1%

Q4.22

arrow
arrow

957

957
vs 833

15%

Q1.23

arrow
arrow

941

941
vs 957

-2%

Q2.23

arrow
arrow

1000

1K
vs 941

6%

Q3.23

arrow
arrow

946

946
vs 1K

-5%

Q4.23

arrow
arrow

1026

1K
vs 946

8%

Q1.24

arrow
arrow

1079

1.1K
vs 1K

5%

Q2.24

arrow
arrow

1032

1K
vs 1.1K

-4%

Earnings Growth

Latest News